University of Notre Dame
Browse

File(s) stored somewhere else

Please note: Linked content is NOT stored on University of Notre Dame and we can't guarantee its availability, quality, security or accept any liability.

In vivo Tumor Growth of High-Grade Serous Ovarian Cancer Cell Lines.

journal contribution
posted on 2022-09-28, 00:00 authored by Anirban K Mitra, Daniel D Lantvit, Daniela Matei, David A Davis, Elizabeth Loughran, Fang Fang, Hilal Gurler, Horacio Cardenas, Jia Xie, Jing YangJing Yang, Joanna E Burdette, Karen D Cowden Dahl, Kenneth P Nephew, Lynn Roy, Sharon StackSharon Stack, Maria V Barbolina, Robert E. Emerson, Sunil Tomar, Yueying LiuYueying Liu
Objective: Genomic studies of ovarian cancer (OC) cell lines frequently used in research revealed that these cells do not fully represent high-grade serous ovarian cancer (HGSOC),the most common OC histologic type. However,OC lines that appear to genomically resemble HGSOC have not been extensively used and their growth characteristics in murine xenografts are essentially unknown. Methods: To better understand growth patterns and characteristics of HGSOC cell lines in vivo,CAOV3,COV362,KURAMOCHI,NIH-OVCAR3,OVCAR4,OVCAR5,OVCAR8,OVSAHO,OVKATE,SNU119 and UWB1.289 cells were assessed for tumor formation in nude mice. Cells were injected intraperitoneally (i.p.) or subcutaneously (s.c.) in female athymic nude mice and allowed to grow (maximum of 90 days) and tumor formation was analyzed. All tumors were sectioned and assessed using H&E staining and immunohistochemistry for p53,PAX8 and WT1 expression. Results: Six lines (OVCAR3,and OVSAHO) formed i.p xenografts with HGSOC histology. OVKATE and COV362 formed s.c. tumors only. Rapid tumor formation was observed for OVCAR3,OVCAR5 and OVCAR8,but only OVCAR8 reliably formed ascites. Tumors derived from OVCAR3,and OVKATE displayed papillary features. Of the 11 lines examined,three (Kuramochi,SNU119 and UWB1.289) were non-tumorigenic. Conclusions: Our findings help further define which HGSOC cell models reliably generate tumors and/or ascites,critical information for preclinical drug development,validating in vitro findings,imaging and prevention studies by the OC research community.

History

Date Modified

2022-09-29

Language

  • English

Publisher

Gynegologic Oncology

Usage metrics

    Harper Cancer Research Institute

    Categories

    No categories selected

    Keywords

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC